Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.06 INR | +1.52% |
|
+0.46% | +12.12% |
26/06 | Yes Bank Gets Board Nod to Raise Funds via Debt Securities | MT |
17/06 | Fortis, Apollo, Medanta, and Max Lead the Charge in Bidding War for Jaypee Healthcare | CI |
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 60% by 2026.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company returns high margins, thereby supporting business profitability.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 68.32 times its estimated earnings per share for the ongoing year.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Banks
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+12.12% | 8.91B | - | ||
+18.91% | 581B | C+ | ||
+18.12% | 311B | C+ | ||
+21.47% | 263B | C+ | ||
+24.09% | 187B | B- | ||
+29.19% | 175B | B- | ||
+8.52% | 158B | C+ | ||
-0.24% | 154B | B- | ||
+8.69% | 150B | B- | ||
+12.88% | 142B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- YESBANK Stock
- YESBANK Stock
- Ratings Yes Bank Limited